Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/tag-1/yeas/) was not found.

Search tag 1 yeas at Google

Search tag 1 yeas at Yahoo

Search tag 1 yeas at Msn

Google
 
(Date:3/11/2010)... promise of stem cells lies in their unique ability to ... in order to determine how to use stem cells for ... question: if a stem cell changes to look like a ... will behave like a certain type of cell? , Researchers ... to fully characterize a special type of stem cell, endothelial ...
(Date:3/11/2010)... in both the developing and developed world may ... University of Pennsylvania School of Veterinary Medicine. , ... system operates, have discovered a previously unidentified cell ... fighting off parasitic infections but also causing the ... and asthma. , This cell population, termed multipotent ...
(Date:3/11/2010)... Spanish . , A shipment of seed ... month to the Svalbard Global Seed Vault in Norway ... braved bears and volcanoes to collect. , The seed ... semi-dwarf wheat and rice cultivars, and other samples maintained ... goal, over the next 10 to 15 years, is ...
Breaking Biology News(10 mins):Researchers characterize stem cell function 2Penn researchers identify immune cells that fight parasites may promote allergies and asthma 2ARS sends third seed shipment to Norway seed vault 2OncoGenex Reports Second Quarter 2009 Financial Results 13426 1OncoGenex Reports Second Quarter 2009 Financial Results 13426 2OncoGenex Reports Second Quarter 2009 Financial Results 13426 3OncoGenex Reports Second Quarter 2009 Financial Results 13426 4OncoGenex Reports Second Quarter 2009 Financial Results 13426 5OncoGenex Reports Second Quarter 2009 Financial Results 13426 6OncoGenex Reports Second Quarter 2009 Financial Results 13426 7Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2Scientists find universal rules for food web stability 9510 1Scientists find universal rules for food web stability 9510 2
(Date:3/14/2010)... in shielding users from cardiovascular woes, study finds , , ... available drugs could help prevent diabetes and the problems ... have been dashed by a major international study. , ... -- Diovan (valsartan), a blood pressure medication; and Starlix ... diabetes. , The study was financed by Novartis, ...
(Date:3/14/2010)... pressure to normal levels below currently recommended ... risk of fatal or nonfatal cardiovascular disease events ... at especially high risk for cardiovascular disease events, ... to Control Cardiovascular Risk in Diabetes (ACCORD) clinical ... drug therapy of a fibrate and a statin ...
(Date:3/14/2010)... the benefits of acupuncture, hypnosis and neuroprogramming without the expense ... love to be able to Quit Smoking, Lose Weight and ... ... (PRWEB) March 14, 2010 -- AcuAids announces acupuncture at home ... Key features include the ability to experience the ...
(Date:3/13/2010)... GA MARCH 13, 2010 The announcement ... Xience Prime versus Coronary Artery Bypass Surgery for ... drug-eluting stents to coronary artery bypass graft surgery ... was made today at "Optimizing PCI Outcomes: Evolving ... Foundation. , "While the SYNTAX trial suggested that ...
(Date:3/13/2010)... weighs heavily on the hearts of police, firefighters , , ... on 9/11 to the collapsing World Trade Center towers ... compared with people in the general population, a new ... Saturday at the American College of Cardiology,s annual meeting, ... suggest a potential link between exposure to Ground Zero ...
Breaking Medicine News(10 mins):Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 2Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 4Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 5Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 6Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 2Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 3Health News:EXCEL trial will determine safety and efficacy of drug-eluting stents vs. bypass surgery 2Health News:Many WTC Responders Show Signs of Heart Trouble 2Health News:Many WTC Responders Show Signs of Heart Trouble 3
... peptide whose sequences are derived from mouse resistin protein. The ... S - M - P - L - C - P ... D - K - K - I - K - Q ... for neutralization and control experiments with the polyclonal antibody that reacts ...
... Custom peptide microarrays designed for quantitative ... samples and built on the flexible ... Thousands of customer specified sequences can ... can provide assistance with custom sequence ...
... a 16 amino acid (amino acids 3-18) synthetic peptide whose ... sequence of this peptide is (amino to carboxy terminus): Q(3) ... - K - L - R - A - L ... This peptide may be used for neutralization and ...
... Chemicon Select Tissue Arrays are intended ... individual tissues were fixed in neutral buffered ... identification and diagnosis was performed by certified ... their paraffin blocks and relocated into a ...
Biology Products:
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... either EDTA K2 or EDTA K3 ... and therefore blocks the coagulation cascade. ... EDTA anticoagulated blood sample are stable ... tubes are for the examination of ...
... is the most powerful, ... Easy-to-use and rich in ... with a comprehensive authoring ... delivering custom interactive multimedia ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products:
(Date:3/11/2010)... Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts Conventional Energy seminar , ... , ... ... ... EDMONTON , March 11 /PRNewswire/ - Today at ACAMP,s ...
(Date:3/11/2010)... , March 11 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical ... definitive license agreements with University Health Network (UHN) and The Hospital for Sick ... commercialize two immunology programs in the areas of hematopoietic stem cell transplantation and ... ... ...
(Date:3/10/2010)... March 11 Thomson Reuters today announced it has launched ... Times Higher Education,s influential World University Rankings. The survey reflects a ... to the global scholarly community. , ... ... ...
(Date:3/10/2010)... March 10, 2010 Complete Genomics Inc., ... that the Institute for Systems Biology (ISB) employed ... a family quartet to determine the depth of ... sequence, and to verify the gene responsible for ... collaboration will be published online later today in ...
Breaking Biology Technology:Alberta companies delivering new products to the Conventional Energy marketplace 2Alberta companies delivering new products to the Conventional Energy marketplace 3Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 2Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Institute for Systems Biology uses Complete Genomics' genome sequencing service to verify gene responsible for Miller syndrome 2
(Date:3/12/2010)... SALT LAKE CITY , March 12 Otix Global, Inc. (Nasdaq: ... stock split at a 1-for-5 ratio of its outstanding common stock.  The reverse stock ... 2009 , and is expected to be effective on or about March 29, ... ... ...
(Date:3/12/2010)... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today the appointment of Julie McHugh as the company,s chief operating officer, effective March 15, ... ... ... ... ...
(Date:3/12/2010)... March 12 /PRNewswire-Asia/ -- ... Phase II trial of nemonoxacin (TG-873870) ... dosing met the primary endpoints and,showed ... Nemonoxacin is a,novel non-fluorinated quinolone that ... against,gram-positive and gram-negative bacteria and atypical ...
Breaking Medicine Technology:Otix Global, Inc. Announces Reverse Stock Split 2Otix Global, Inc. Announces Reverse Stock Split 3Otix Global, Inc. Announces Reverse Stock Split 4Otix Global, Inc. Announces Reverse Stock Split 5Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 2Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 3Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 4Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 5Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer 6TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 2TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints 3One of the Nation 26apos 3Bs Leading Analytical Testing Laboratories is Now Easier to Access Pace Analytical Launches New Web Site to Showcase Its 13424 1One of the Nation 26apos 3Bs Leading Analytical Testing Laboratories is Now Easier to Access Pace Analytical Launches New Web Site to Showcase Its 13424 2IRIDEX Announces Second Quarter 2009 Conference Call and Release Date 53886 1Rapid Swine Flu Test Misses Many Infections 53883 1Rapid Swine Flu Test Misses Many Infections 53883 2Rapid Swine Flu Test Misses Many Infections 53883 3